| Dr Thomas Andrew Greenwald, MD | |
|
1215 Duff Ave, Ames, IA 50010-3014 | |
| (515) 239-4475 | |
| (515) 239-4722 |
| Full Name | Dr Thomas Andrew Greenwald |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 1215 Duff Ave, Ames, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497743314 | NPI | - | NPPES |
| 0087460 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 28613 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
BioSante Pharmaceuticals, Inc., today announced an exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation, a charitable foundation that supports research to address life-threatening medical conditions and significant disabilities.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.
Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by global market intelligence firm, IDC, in the "IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment," (doc #HI255628, April 2015) report.
› Verified 3 days ago
| Entity Name | Mcfarland Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
BioSante Pharmaceuticals, Inc., today announced an exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation, a charitable foundation that supports research to address life-threatening medical conditions and significant disabilities.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.
Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by global market intelligence firm, IDC, in the "IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment," (doc #HI255628, April 2015) report.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Andrew Greenwald, MD 1215 Duff Ave, Ames, IA 50010-3014 Ph: (515) 239-4475 | Dr Thomas Andrew Greenwald, MD 1215 Duff Ave, Ames, IA 50010-3014 Ph: (515) 239-4475 |
News Archive
BioSante Pharmaceuticals, Inc., today announced an exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation, a charitable foundation that supports research to address life-threatening medical conditions and significant disabilities.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.
Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by global market intelligence firm, IDC, in the "IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment," (doc #HI255628, April 2015) report.
› Verified 3 days ago
Dr. David Kent Sneller, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 Fax: 515-239-4722 | |
Dr. Michael Stefl, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 | |
Dr. James Andrew Friederich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 Fax: 515-239-4722 | |
Betsey Katherine Bean, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 | |
Peter Goodrich Buck, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 Fax: 515-239-4722 | |
Jonathon Ross Geisinger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 Fax: 515-239-4722 | |
Christy Christophersen, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4475 |